Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M260Revenue (TTM) $M25.9Net Margin (%)-255.8Altman Z-Score-11.3
Enterprise Value $M173EPS (TTM) $-0.7Operating Margin %-257.3Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-255.8Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio4.2Cash flow > EarningsN
Price/Sales9.15-y EBITDA Growth Rate %--Current Ratio4.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-58.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-82.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M94.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with RIGL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RIGLJohn Paulson 2016-09-30 Reduce$2.13 - $3.93
($2.87)
$ 2.63-8%Reduce -19.48%805,000
RIGLJohn Paulson 2016-03-31 Add0.01%$1.94 - $3.03
($2.48)
$ 2.636%Add 89.09%999,700
RIGLCharles Brandes 2016-03-31 Sold Out $1.94 - $3.03
($2.48)
$ 2.636%Sold Out0
RIGLJohn Paulson 2015-12-31 Buy 0.01%$2.53 - $3.55
($3.05)
$ 2.63-14%New holding528,700
RIGLCharles Brandes 2015-09-30 Reduce$2.36 - $3.35
($2.98)
$ 2.63-12%Reduce -44.07%25,000
RIGLCharles Brandes 2015-03-31 Buy $2.06 - $3.68
($2.74)
$ 2.63-4%New holding44,700
RIGLCharles Brandes 2014-09-30 Sold Out $1.97 - $3.84
($2.81)
$ 2.63-6%Sold Out0
RIGLCharles Brandes 2014-03-31 Buy $2.7 - $4.75
($3.53)
$ 2.63-25%New holding15,000
RIGLGeorge Soros 2011-12-31 Sold Out -0.0019%$6.68 - $8.3
($7.59)
$ 2.63-65%Sold Out0
RIGLFirst Eagle Investment 2011-06-30 Sold Out $7.11 - $9.19
($8.07)
$ 2.63-67%Sold Out0
RIGLGeorge Soros 2011-06-30 Buy $7.18 - $9.19
($8.08)
$ 2.63-67%New holding14,500
RIGLFirst Eagle Investment 2011-03-31 Buy $6.54 - $7.74
($7.06)
$ 2.63-63%New holding46,700
RIGLGeorge Soros 2010-09-30 Sold Out $6.94 - $8.8
($8.11)
$ 2.63-68%Sold Out0
RIGLGeorge Soros 2010-03-31 Add$7.41 - $9.83
($8.55)
$ 2.63-69%Add 34.29%14,100
RIGLGeorge Soros 2009-12-31 Buy $6.08 - $9.86
($7.86)
$ 2.63-67%New holding10,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RIGL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RIGL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAYAN DONALD GEVP, Pres. Discovery&Research 2016-08-30Sell5,303$4-34.25view
PAYAN DONALD GEVP, Pres. Discovery&Research 2015-06-10Sell41,666$3.68-28.53view
PAYAN DONALD GEVP, Pres. Discovery&Research 2015-04-01Sell10,000$3.75-29.87view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2218.47view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2218.47view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-09-03Sell20,000$2.562.73view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-02-24Sell20,000$3.71-29.11view
BVF PARTNERS L P/IL10% Owner 2013-11-19Sell484,622$2.64-0.38view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy32,700$3.47-24.21view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2012-09-13Sell4,151$10.43-74.78view

Quarterly/Annual Reports about RIGL:

News about RIGL:

Articles On GuruFocus.com
Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 
Rigel Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 01 2011 

More From Other Websites
Hedge Funds Think The Sky’s The Limit For Horizon Global Corp (HZN) Nov 28 2016
Rigel to Present at Jefferies 2016 London Healthcare Conference Nov 10 2016
RIGEL PHARMACEUTICALS INC Financials Nov 08 2016
ETF’s with exposure to Rigel Pharmaceuticals, Inc. : November 4, 2016 Nov 04 2016
Rigel Pharmaceuticals, Inc. :RIGL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016 Nov 03 2016
Edited Transcript of RIGL earnings conference call or presentation 1-Nov-16 9:00pm GMT Nov 02 2016
Rigel reports 3Q loss Nov 01 2016
Rigel reports 3Q loss Nov 01 2016
RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 01 2016
Rigel Announces Third Quarter 2016 Financial Results and Provides Company Update Nov 01 2016
Rigel Announces Third Quarter 2016 Financial Results and Provides Company Update Nov 01 2016
Q3 2016 Rigel Pharmaceuticals Inc Earnings Release - After Market Close Nov 01 2016
Rigel Announces Conference Call and Webcast to Report Third Quarter 2016 Financial Results Oct 28 2016
Rigel Announces Conference Call and Webcast to Report Third Quarter 2016 Financial Results Oct 28 2016
4 Companies That Destroyed Shareholders Last Week Oct 23 2016
Rigel Tanks After Late-Stage Drug Failure (RIGL) Oct 21 2016
Rigel’s stock rocked as all-in drug disappoints in late-stage trial Oct 20 2016
Why Rigel Pharma Is Falling Oct 20 2016
Why Rigel Pharmaceuticals, American Airlines, Facebook, and More Are in the Spotlight Oct 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)